Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
2000 1
2001 2
2004 1
2006 1
2007 3
2008 3
2009 4
2010 2
2011 3
2012 1
2013 7
2014 4
2015 7
2016 6
2017 7
2018 17
2019 16
2020 17
2021 10
2022 3
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.
Jacobson CA, Chavez JC, Sehgal AR, William BM, Munoz J, Salles G, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Yakoub-Agha I, Oluwole OO, Fung HCH, Rosenblatt J, Rossi JM, Goyal L, Plaks V, Yang Y, Vezan R, Avanzi MP, Neelapu SS. Jacobson CA, et al. Among authors: william bm. Lancet Oncol. 2022 Jan;23(1):91-103. doi: 10.1016/S1470-2045(21)00591-X. Epub 2021 Dec 8. Lancet Oncol. 2022. PMID: 34895487 Clinical Trial.
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators. Kim YH, et al. Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Lancet Oncol. 2018. PMID: 30100375 Free article. Clinical Trial.
Age is No Barrier: CAR-T Therapy in Older Adults.
Maakaron JE, William BM. Maakaron JE, et al. Among authors: william bm. Drugs Aging. 2023 Aug;40(8):685-689. doi: 10.1007/s40266-023-01047-z. Epub 2023 Jul 11. Drugs Aging. 2023. PMID: 37432595 Review.
Editorial: Cutaneous T-Cell Lymphomas.
Chung CG, William BM. Chung CG, et al. Among authors: william bm. Front Oncol. 2021 Feb 9;11:649714. doi: 10.3389/fonc.2021.649714. eCollection 2021. Front Oncol. 2021. PMID: 33634035 Free PMC article. No abstract available.
I-131 tositumomab.
William BM, Bierman PJ. William BM, et al. Expert Opin Biol Ther. 2010 Aug;10(8):1271-8. doi: 10.1517/14712598.2010.504707. Expert Opin Biol Ther. 2010. PMID: 20590521 Review.
Bortezomib for the treatment of mantle cell lymphoma: an update.
Hambley B, Caimi PF, William BM. Hambley B, et al. Among authors: william bm. Ther Adv Hematol. 2016 Aug;7(4):196-208. doi: 10.1177/2040620716648566. Epub 2016 May 21. Ther Adv Hematol. 2016. PMID: 27493710 Free PMC article. Review.
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021.
Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kim YH, Mehta-Shah N, Olsen EA, Pro B, Rajguru SA, Rozati S, Said J, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala C, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H. Horwitz SM, et al. Among authors: william bm. J Natl Compr Canc Netw. 2020 Nov 2;18(11):1460-1467. doi: 10.6004/jnccn.2020.0053. J Natl Compr Canc Netw. 2020. PMID: 33152703
105 results